Drugs / SII Inactivated Salk Polio Vaccine (Adsorbed)
SII Inactivated Salk Polio Vaccine (Adsorbed)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05163561 | Jan 2022 → Apr 2023 | poliomyelitis | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SII Inactivated Salk Polio Vaccine (Adsorbed) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05163561 ↗ |
| Modality | Vaccine | “inactivated poliovirus vaccine” NCT05163561 ↗ |
| Route | Intramuscular | “Three intramuscular doses (0·5 mL) were administered at age 6, 10, and 14 weeks” PMID 40505670 ↗ Jun 2025 |